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Site-directed mutagenesis and X-ray absorption spectroscopy studies have previously
shown that the tRNA-guanine transglycosylase (TGT) from Escherichia coli is a zinc
metalloprotein and identified the enzymic ligands to the zinc [Chong et al. (1995),
Biochemistry 34, 3694-3701; Garcia et al. (1966), Biochemistry 35, 3133-3139]. During
these studies one mutant, TGT (C265A), was found to exhibit a significantly lower specific
activity, but was not found to be involved in the zinc site. The present report demonstrates
that TGT is inactivated by treatment with thiol reagents (e.g., DTNB, MMTS, and
N-ethylmaleimide). Further, this inactivation is shown to be due to modification of cysteine
265. The kinetic parameters for the mutants TGT (C265A) and TGT (C265S), however,
suggest that this residue is not performing a critical role in the TGT reaction. We conclude
that cysteine 265 is in the active site of TGT, but is not performing a critical catalytic
function. This conclusion is supported by the recent determination of the X-ray crystal
structure of the TGT from Zymomonas mobilis [Romier et al. (1966), EMBO J. 15,
2850-2857], which reveals that the residue corresponding to cysteine 265 is distant from
the putative catalytic site, but is in the middle of a region of the enzyme surface proposed
to bind tRNA.
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1. INTRODUCTION
tRNA-guanine transglycosylase (TGT)4 is a key
enzyme involved in the post transcriptional
modification of tRNA with the hypermodified base
queuine (7-(4,5-c«-dihydroxy-l-cyclopenten-3-yl
aminomethyl)-7-deazaguanine). In Escherichia coli
the enzyme catalyzes the exchange of a queuine
precursor (preQ,, 7-aminomethyl-7-deazaguanine)
into tRNA (Okada et al., 1979). This precursor is
further modified to queuine by two subsequent
enzymatic steps (Nishimura, 1983).
An E. coli mutant described by Noguchi et al.
(1982) contains tRNA lacking the hypermodified
wobble nucleoside queosine (Q) due to an inactive
tRNA-guanine transglycosylase (TGT). The mutant
tgt gene was cloned and sequenced; it contained a
single point mutation resulting in the change of
serine 90 to phenylalanine (Reuter et al., 1994).
Studies of TGT (S90A) and TGT (S90C) mutants
indicate that serine 90 is performing a critical role
in the TGT reaction (Reuter et al., 1994).
Homology of the serine 90 site (DSGG) to the
active-site serine of trypsin suggests that TGT may
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utilize a serine protease-type nucleophilic catalysis
mechanism.
Our early, unpublished observations that the
E. coll TGT was susceptible to thiol reagents led us
to the discovery that TGT is a zinc metalloenzyme.
Site-directed mutagenesis studies (Chong et al,
1995) established that cysteines 302, 304, and 307
constitute three of the four TGT ligands to the zinc.
These studies in addition to X-ray absorption
studies (Garcia et al., 1996) suggested that histidine
317 served as the fourth ligand to the zinc. The very
recent determination of the X-ray crystal structure
of the TGT from Zymonomas mobilis (Romier et
al., 1996) confirmed the identity of the three
cysteine zinc ligands. However, the residue
corresponding to histidine 333 was found to be the
fourth ligand to the zinc. Histidine 317 was
proposed to be involved in the subunit interface in
the E. coli TGT, accounting for our observations.
Other than the three zinc-ligand cysteines, only one
of the eight cysteine-to-alanine mutations yielded a
TGT exhibiting a significant reduction in activity.
However, this mutant, C265A, was identical to
wild-type TGT in quaternary structure and zinc
content, and retained the ability to bind tRNA.
These observations led to the present study,
which establishes that the E. coli TGT can be
inactivated by treatment with thiol reagents. The
results suggest that cysteine 265 is the residue that
is responsible for the inactivation and therefore
must be in the TGT active site. However, the
activities of the cysteine 265 mutants suggest that
this residue is not performing a critical role in
catalysis. These conclusions are supported by
TGTtRNA complex modeling experiments that
suggest that cysteine 265 is on a region of the
surface of TGT where tRNA binds (Romier et al.,
1996).
2. MATERIALS AND METHODS
Buffers were from Sigma. The tRNA used (E.
coli tRNATyr) was prepared from an in vitro
expression system as described previously (Curnow
et al., 1993).
2.1. TGT (wt) and TGT (C265A) Preparation
TGT (wt) was purified as described previously
(Chong and Garcia, 1994b; Garcia et al., 1993). The
TGT (C265A) mutant was prepared as described
previously (Chong et al., 1995).
2.2. Construction, Overexpression, and
Purification of TGT (C265S)
TGT (C265S) was generated by the "preferen-
tial PCR" method (Chong and Garcia, 1994a). The
mutagenic primer was
5'-GGTTGGCATTACGGAGTCAAACATATC-3'
(mutated codon underlined). The wild-type and
mutant TGTs were overexpressed in a tgt~ strain of
E. coli, E. coli K12 (Argf)/pLysS, provided by Prof.
H. Kersten (University of Erlangen-Nlirnberg). The
overexpression and purification were performed
following the protocols described previously
(Chong et al., 1995).
2.3. Kinetic Assays
Assays to determine the kinetic parameters for
the tRNA substrate were carried out in a 300- ,̂1
reaction mixture containing 100 mM HEPES,
pH7-5, 20mMMgCl2, SmMDTT, 40ju,M [8-
14C]guanine, and from 0.24 to 26 ̂ M tRNA. The
enzyme concentration was 173 nM for TGT
(C265A), 85 nM for TGT (C265S), or 62 nM for
TGT (wt). The assays for the determination of the
kinetic parameters for guanine were carried out in
the same buffer system in the presence of
20(U,MtRNA (for C265A and wild-type) or 26/nM
(for C265S). The concentration of [8-14C]guanine
was varied from 0.05 to 20/iM. The reaction
mixtures were incubated at 37°C and aliquots
(70 n,\) were taken at various time points. Initial
velocities were determined by linear regression of
dpm versus time plots. Michaelis-Menten para-
meters were determined from the initial velocities
by nonlinear regression analysis.
2.4. Physical Characterization of TGT Mutants
The purified TGT (C265A) and TGT (C265S)
mutants were characterized by SDS-PAGE, native
PAGE [including the tRNA "bandshift" assay on
native-PAGE (Curnow and Garcia, 1994)], zinc
content, and CD spectra following the procedures
described previously (Chong et al., 1995). Enzyme
concentrations were determined spectrophoto-
metrically using an absorption coefficient of
E. coli tRNA-Guanine Transglycosylase 13
l.l4mg/mL/OD28o previously corrected by total
amino acid analysis (Chong et al, 1995). For the
native-PAGE bandshift assay 10/iMTGT (wt),
l.SjuMTGT (C265A), and 2/iMTGT (C265S)
were incubated either in buffer (25mMHEPES,
pH7.5, 5 mMDTT) alone (odd lanes) or with
50 /A M tRNA (even-numbered lanes) for 15 min at
37°C prior to applying 5 /tl of each sample to the
gel. The native-PAGE was run on an 8-25%
gradient gel following the vendor's protocols
(Pharmacia Phastsystem).
2.5. Inhibition of TGT Activity by Thiol Reagents
TGT (wt) was depleted of exogenous thiols
(i.e., DTT) by desalting into degassed
25mMHEPES buffer (pH7.8) using a Fast
Desalting column (HR 10/10, Pharmacia) or by
dialyzing against the degassed 25 mM HEPES
buffer (pH7.5). TGT (wt), 7.6 /iM in a final
volume of 50 /A!, was incubated at room tempera-
ture with increasing amounts of thiol reagents
(from 1 to 17.5 ju,M) for 10 min (in the case of
DTNB and MMTS) or 90 min (in the case of
N-ethylmaleimide). The reaction was stopped by
diluting the reaction mixture 100-fold. The specific
activity of the diluted enzyme was determined using
standard buffer conditions (see above) and
saturating concentrations of guanine and tRNA.
These values were plotted against the mole ratio of
reagent versus enzyme (Fig. 3A). As a reference,
TGT specific activity was determined under the
same conditions in the absence of thiol reagent and
was set to 100%.
2.6. DTT Reversal of Thiol Reagent Inhibition of
TGT Activity
The experiment was performed as above
except that only one concentration (15 ptM) of the
thiol reagent was used and 10 mM DTT was present
during the dilution of the reaction mixture and in
the activity assay (Fig. 3B).
2.7. Substrate Protection of TGT from the
Inhibition by Thiol Reagents
TGT (15.2/iM) was first incubated with
40/tM tRNA at 37°C for 20 min. The substrate-
protected TGT was then incubated with 15 //.M
thiol reagent (7.6 /u,M enzyme) for 60 min. The
reaction was stopped by diluting the reaction
mixture 100-fold. The TGT activity was then
determined as above (Fig. 3B).
2.8. DTNB Titration of TGT (wt) and TGT
(C265S)
The method used was according to Habeeb
(1971) with some modifications. TGT (wt) (6/tM)
and TGT (C265S) (4.5 /xM, depleted of exogenous
thiols as described above for wt), prepared as
described above, were individually mixed with
DTNB (ImM in 25 mM HEPES, pH7.8) and the
absorbance at 412 nm was immediately followed as
a function of time in a Gilford Response® UV/VIS
spectrophotometer. The net absorbance was con-
verted into concentration using the molar extinction
coefficient for the nitrobenzoate thiolate chro-
mophore of 13,600 OD M"1 cm1 at 412 nm. The
number of the titrated sulfhydryl groups per
monomer TGT was plotted as a function of
titration time (Fig. 4).
The specific activities of DTNB-modified
wild-type and mutant enzymes were also deter-
mined. TGT (wt) (7.5 fiM) or TGT (C265S)
(9 (J-M), in a final volume of 20 /itl, were incubated
at room temperature with increasing amounts of
DTNB [3.7, 7.5, and 15 /iM for wild-type TGT, 4.5,
9, 18 IJ.M for TGT (C265S)] for 10 min. Three
replicate determinations were performed at each
DTNB concentration. The averages of these
determinations were then plotted versus mole ratio
DTNB (Fig. 5).
3. RESULTS
3.1. Overexpression and Purification of TGT
(C265S)
The TGT (C265S) mutant was generated by a
"preferential PCR" method (Chong and Garcia,
1994a). The mutated TGT gene insert was
sequenced to verify successful mutagenesis and the
absence of adventitious mutations. TGT (C265S)
was overexpressed in the E. coli K12 (Afgf)/pLysS
strain to exclude wild-type TGT contamination.
The mutant protein expression level was similar to
that of wild-type TGT (data not shown). TGT
(C265A) and TGT (C265S) mutants were purified
to homogeneity as previously described (Chong et
al., 1995).
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Fig. 1. Native-PAGE bandshift assay. Lanes 1 and 2; TGT (wt);
3 and 4; TGT (C265A); 5 and 6, TGT (C265A), in the absence
(odd-numbered lanes) and presence (even-numbered lanes) of
tRNA.
3.2. Physical Characterization of TGT (C265A)
and TGT (C265S)
Native-PAGE (Fig. 1) showed that both
mutants retained the trimeric gross structure
identical to the wild-type enzyme and exhibited a
bandshift after incubation with the substrate tRNA,
indicating that they retained the ability to bind
tRNA. The zinc contents of these two mutants were
determined to be 0.82 ± 0.04 per monomer enzyme
for C265A and 0.85 ± 0.03 per monomer enzyme
for C265S. Wild-type TGT contains from 0.76 to
0.85 zinc atoms per monomer, varying with the
preparation (Chong et al, 1995).
The CD spectra of TGT (C265A) and TGT
(C265S) were very similar to that of wild-type TGT
(Fig. 2). The secondary structural elements were
Fig. 2. CD spectra of TGT (wt), TGT (C265S), and TGT
(C265A).
predicted following the method of Johnson (1990)
from the CD data using Young's Protein Secondary
Structure Program (Jasco Inc.). The TGT (C265A)
mutant was predicted to have 65% a-helix, no
)3-sheet, 21% £ -turn, and 14% random coil,
whereas TGT (C265S) was predicted to have 79%
a-helix, no /3-sheet, 16% ^-turn, and 6% random
coil. These predicted values are very similar to
those for wild-type TGT, which were found
previously to be 70 ± 3% a-helix, no /3-sheet,
19 ±1% j3-turn, and 12 ±1% random coil (Chong
et al, 1995).
3.3. DTNB Titration of TGT (wt) and TGT
(C265S)
Modification of wild-type TGT with ca. 1.5
equivalents of DTNB completely inactivates the
enzyme (Fig. 3A). Similar results are achieved
when methylmethanethiosulfonate (MMTS) or
N-ethylmaleimide (NEM) are used (Fig. 3A).
Preincubation of enzyme with substrate tRNA
protects TGT from inactivation by treatment with
thiol reagents (Fig. 3B). In the cases of DTNB and
MMTS treatment, inactivation can be reversed by
the addition of dithiothreitol (Fig. 3B).
Treatment of TGT (wt) with excess DTNB
under native conditions titrates two thiols immedi-
ately and a third thiol is titrated after ca. 15 min
(Fig. 4). Under denaturing conditions (3% SDS),
two to three thiols are titrated immediately and a
total of ca. eight thiols are titrated within 5 min
(data not shown). This is consistent with the
number of cysteines (eight per monomer) predicted
from the tgt gene sequence. Treatment of TGT
(C265S) with excess DTNB under native conditions
yields one less thiol titrated than does TGT (wt)
treated in an identical fashion (Fig. 4).
3.4. DTNB Inactivation of TGT (wt) and TGT
(C265S)
DTNB titrations of TGT (wt) and TGT
(C265S) were conducted and the specific activities
of the treated enzymes were determined at various
concentrations of DTNB. The results (Fig. 5)
indicate that TGT (C265S) retained more than 75%
of its activity when the enzyme was treated with
two equivalents of DTNB. Under the same
conditions wild-type enzyme retained only 2% of its
original activity.
E. coll tRNA-Guanine Transglycosylase 15
Fig. 3. Inactivation of TGT (wt%) by thiol reagents. (A) Inhibition of TGT activity by thiol
reagents. The lines are linear fits of the initial portions (the first five or six points) of the
titrations. (B) Effect of adding DTT and the substrate tRNA on the inhibition by thiol
reagents. The data plotted are averages of at least two replicate experiments.
3.5. Determination of Kinetic Parameters of TGT
Mutants
The kinetic parameters of TGT (C265A) and
TGT (C265S) were determined. Compared to
wild-type TGT, the mutation of cysteine 265 to
alanine did not cause a large change in KM for
either substrate (Table I). The mutation decreased
ymax to ca. 20% of the value for the wild-type. The
catalytic efficiency represented by Vm!LJKM was
decreased by ca. 90% for tRNATyr and 70% for
guanine compared to the wild-type. The mutation
of cysteine 265 to serine resulted in only small
changes in KM and Vmax. Compared to the result for
the wild-type, KM for tRNATyr increased 1.5-fold
and KM for guanine twofold. The mutant retained
approximately 70% of the wild-type Vmax.
4. DISCUSSION
The primary sequence of TGT from E. coli
contains eight cysteine residues in the monomer. In
the native state two equivalents of cysteine are
immediately titrated and a third cysteine is titrated
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Fig. 4. DTNB titration of TGT (wt) and TGT (C265S). TGT (wt) is represented by the filled
circles and TGT (C265S) is represented by the open circles. Samples were titrated under
conditions of excess DTNB as described in Materials and Methods.
within 20 min (Fig. 4). All three thiol reagents
(DTNB, MMTS, and NEM) were found to inhibit
the activity of TGT. In order to determine if there
was a linear relationship between the amount of
thiol reagents added and their capacity to inhibit
TGT, the percentage activity was plotted as a
function of the amount of thiol reagent added per
mole of the enzyme. As shown in Fig. 3A, TGT is
completely inactivated by treatment with between
Fig. 5. Effect of DTNB modification on the activities of TGT
(wt) and TGT (C265S). The solid line is for wild-type TGT and
the dashed line is for TGT (C265S). The data were obtained
from the average of three replicate determinations at each
DTNB concentration. The standard deviations are represented
by error bars (some are too small to be visible). For ease of
comparison the activities plotted are relative to the specific
activity of the untreated enzyme. Note that the absolute specific
activity of TGT (C265S) is ca. 50% of that for the wild type.
one and two equivalents of thiol reagent. The
near-complete reversal of DTNB and MMTS
inhibition of the TGT activity by treatment with
DTT (Fig. 3B) is consistent with the formation of
intermolecular disulfide bonds between TGT and
the reagents. In the case of N-ethylmaleimide,
treatment with DTT did not reverse the inhibition,
consistent with the formation of a thio-ether bond
between TGT and this reagent (Fig. 3B). Substrate
tRNA fully protected TGT from inhibition by
DTNB and N-ethylmaleimide, and 75% protection
was achieved in the case of MMTS (Fig. 3B). These
results suggest that the cysteine residue titrated by
the thiol reagents is located in or very near the
active site of TGT and may be involved in the
catalysis of the TGT reaction.
Of the eight cysteine-to-alanine TGT mutants
studied previously (Chong et al, 1995) TGT
(C265A) was the only mutant that had a significant
loss in activity while still maintaining the wild-type
zinc content and gross structure. Cysteine 265 is
conserved in the TGT genes from E. coli and Z.
mobilis, which share only 50% identity at the
amino acid level (Reuter and Ficner, 1995). It is
also located in the middle of a stretch of 12
conserved amino acids. It was therefore speculated
that cysteine 265 might serve a key catalytic role in
the TGT reaction mechanism. Changing cysteine
265 into alanine results in only a tenfold decrease in
E, coli tRNA-Guanine Transglycosylase 17
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the catalytic efficiency (Vmax/KM), whereas a
previously described serine-90-to-alanine mutation
causes approximately four orders of magnitude
decrease in activity (Reuter et al, 1994). Kinetic
studies on TGT (C265S) show that this mutant
enzyme retains 70% of the wild-type Vmax, VmaJKM
for tRNA is 50% of the wild-type value, and
VmJKM for guanine is 40% (Table I). This does
not support a key catalytic role for cysteine 265 in
the TGT reaction.
If cysteine 265 is the enzymic residue that is
modified by the thiol reagents leading to inactiva-
tion of wild-type TGT, then one would expect that
the C265S mutant would no longer be susceptible
to inactivation by treatment with thiol reagents.
Figure 5 shows that the activity of TGT (C265S)
does not change significantly when treated with
varying amounts of DTNB. Under the same
conditions, wild-type TGT is essentially totally
inactivated by the addition of two equivalents of
DTNB. These studies indicate that it is DTNB
modification of cysteine 265 in wild-type TGT
which results in the inactivation of the enzyme. This
suggests that cysteine 265 is located in or very near
the active site. However, the activities of the C265S
and C265A mutants clearly indicate that this
residue is not performing a key role in catalysis.
The higher activity of the C265S mutant relative to
the C265A mutant suggests that polarity or
hydrogen bonding ability may be involved in the
role of cysteine 265.
These conclusions are supported by the
recently published X-ray crystal structure of the
TGT from Z. mobilis (Romier et al., 1996), which
reveals that cysteine 265 is on the surface of the
enzyme. A model of tRNA bound to the enzyme
(the structure of the TGT-tRNA complex was not
determined) suggests that cysteine 265 lies under-
neath the tRNA and may contribute to tRNA
binding. The authors state that cysteine 265 is too
far from the preCh binding site to have a role in
catalysis. The model of the TGT-tRNA complex is
entirely consistent with the results presented here,
which include substrate protection of the enzyme
against thiol reagents. The structural model is also
consistent with the conclusion that the enzyme is
inactivated by chemical modification of cysteine 265
with thiol reagents because they impair the
enzyme's ability to bind tRNA.
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